Pages that link to "Q34348368"
Jump to navigation
Jump to search
The following pages link to Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma (Q34348368):
Displaying 50 items.
- Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells (Q24314557) (← links)
- Shc and Enigma are both required for mitogenic signaling by Ret/ptc2. (Q24533621) (← links)
- Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade (Q24550950) (← links)
- Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma (Q24669934) (← links)
- RET/PTC rearrangement in thyroid tumors (Q28214459) (← links)
- Structure and chromosomal locations of mouse steroid receptor coactivator gene family (Q30779792) (← links)
- Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer (Q31074050) (← links)
- Effects of siRNA on RET/PTC3 junction oncogene in papillary thyroid carcinoma: from molecular and cellular studies to preclinical investigations (Q31159590) (← links)
- Diagnostic Limitation of Fine-Needle Aspiration (FNA) on Indeterminate Thyroid Nodules Can Be Partially Overcome by Preoperative Molecular Analysis: Assessment of RET/PTC1 Rearrangement in BRAF and RAS Wild-Type Routine Air-Dried FNA Specimens (Q33624667) (← links)
- Thyroid cancer: current molecular perspectives (Q33760910) (← links)
- Mechanisms of chromosomal rearrangements in solid tumors: the model of papillary thyroid carcinoma (Q33771043) (← links)
- Molecular mechanisms of RET activation in human neoplasia (Q33805762) (← links)
- MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivo (Q34109756) (← links)
- Mouse models of endocrine tumours. (Q34129129) (← links)
- Molecular approaches to thyroid cancer diagnosis (Q34160828) (← links)
- Dasatinib reduces FAK phosphorylation increasing the effects of RPI-1 inhibition in a RET/PTC1-expressing cell line. (Q34258443) (← links)
- Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects (Q34438847) (← links)
- Identification of sumoylation sites in CCDC6, the first identified RET partner gene in papillary thyroid carcinoma, uncovers a mode of regulating CCDC6 function on CREB1 transcriptional activity (Q34474368) (← links)
- Assessment of RET/PTC1 and RET/PTC3 rearrangements in fine-needle aspiration biopsy specimens collected from patients with Hashimoto's thyroiditis. (Q34504355) (← links)
- BAC-FISH assays delineate complex chromosomal rearrangements in a case of post-Chernobyl childhood thyroid cancer (Q34550400) (← links)
- High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma (Q34572289) (← links)
- Low VHL mRNA expression is associated with more aggressive tumor features of papillary thyroid carcinoma. (Q34662980) (← links)
- RET/PTC-induced cell growth is mediated in part by epidermal growth factor receptor (EGFR) activation: evidence for molecular and functional interactions between RET and EGFR. (Q35124840) (← links)
- Targeted treatment of differentiated and medullary thyroid cancer (Q35147151) (← links)
- New therapies for dedifferentiated papillary thyroid cancer (Q35381593) (← links)
- Sorafenib potently inhibits papillary thyroid carcinomas harboring RET/PTC1 rearrangement (Q35570953) (← links)
- DNA copy number changes in thyroid carcinoma (Q35786903) (← links)
- Sympathoadrenal hyperplasia causes renal malformations in Ret(MEN2B)-transgenic mice (Q35787988) (← links)
- RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma. (Q35971877) (← links)
- Mouse models of follicular and papillary thyroid cancer progression (Q35971896) (← links)
- Intracellular signal transduction and modification of the tumor microenvironment induced by RET/PTCs in papillary thyroid carcinoma (Q35977327) (← links)
- RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material (Q36135918) (← links)
- Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70 (Q36357367) (← links)
- New treatment in advanced thyroid cancer (Q36361115) (← links)
- Expression and function of nuclear receptor co-activator 4: evidence of a potential role independent of co-activator activity (Q36382025) (← links)
- Identification and characterization of RET fusions in advanced colorectal cancer (Q36557174) (← links)
- Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements (Q36623366) (← links)
- B-Raf mutation and papillary thyroid carcinoma patients (Q36741221) (← links)
- Personalizing therapy in advanced non-small cell lung cancer (Q36811453) (← links)
- Radiation-induced thyroid cancer: what we have learned from chernobyl (Q36831550) (← links)
- RET signaling in endocrine tumors: delving deeper into molecular mechanisms. (Q36960954) (← links)
- Thyroid carcinoma: molecular pathways and therapeutic targets (Q37147768) (← links)
- What is New on Thyroid Cancer Biomarkers (Q37207279) (← links)
- Translocations in epithelial cancers (Q37363960) (← links)
- Promoter variants in the MSMB gene associated with prostate cancer regulate MSMB/NCOA4 fusion transcripts (Q37641177) (← links)
- RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis (Q37650677) (← links)
- Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer (Q37660065) (← links)
- Triggers for genomic rearrangements: insights into genomic, cellular and environmental influences (Q37806625) (← links)
- Molecular genetics and diagnosis of thyroid cancer (Q37924088) (← links)
- RET TKI: potential role in thyroid cancers. (Q37979656) (← links)